Agenda
The following agenda is for the 2026 IHE Indy Precision Oncology Symposium.
Saturday, August 29th, 2026
| Time | Event/Topic |
|---|---|
| 8:00 AM - 8:30 AM | Introduction and Welcome: Precision Oncologics in Hematologic Malignancies Ruemu Birhiray, MD Clinical Professor of Medicine Marion University – Wood College of Osteopathic Medicine |
| 8:30 AM - 9:00 AM | Precision Oncology Diagnostics: From Biomarker Identification To Clinical Application Anil Sood, MD Professor and Vice Chair for Translational Research in Gynecologic Oncology and Cancer Biology MD Anderson Cancer Center |
| 9:00 AM - 9:30 AM | Advances in Molecularly Targeted Treatment for CNS Malignancies Patrick Y. Wen, MD Director for the Center for Neuro-Oncology Dana-Farber Cancer Institute |
| 9:30 AM - 9:40 AM | Diagnostics and CNS Malignancies Questions and Answers |
| 9:40 AM - 9:55 AM | Coffee Break in Exhibitor Hall |
| 9:55 AM - 10:25 AM | Targeting Oncogenic Drivers in Lung Cancer: The Role of TK Inhibitors Justin F. Gainor, MD Associate Professor of Medicine Harvard Medical School |
| 10:25 AM - 10:55 AM | Immunologic Strategies for Management of Lung Cancer Christine Hann, MD, PhD Associate Professor of Oncology John Hopkins School of Medicine |
| 10:55 AM - 11:25 AM | Advancing Therapeutic Targets in Small Cell Lung Cancer Alex Adjei, MD, PhD Chair of Cleveland Clinic Taussig Cancer Institute |
| 11:25 AM - 11:40 AM | Lung Cancers Questions and Answers |
| 11:40 AM - 12:10 PM | Molecularly Driven Treatment Strategies in Gastrointestinal Oncology Heinz-Josef Lenz, MD Deputy Director for Research Programs USC Norris Comprehensive Cancer Center |
| 12:10 PM - 12:40 PM | Precision Oncology in Pancreato-Biliary Malignancies: Translating Molecular Insights into Therapy Aiwu (Ruth) He, MD, PhD Director of Hepatobiliary Cancer Columbia University Medical Center |
| 12:40 PM - 12:55 PM | Gastrointestinal Cancers Questions and Answers |
| 12:55 PM - 2:00 PM | Lunch |
| 2:00 PM - 2:30 PM | Targeted Treatment Strategies in GU Cancers: Current Advances and Emerging Approaches Scott T. Tagawa MD, MS, FACP, FASCO Medical Director of the Genitourinary Oncology Research Program Weill Cornell Medicine |
| 2:30 PM - 2:35 PM | Genitourinary Cancers Questions and Answers |
| 2:35 PM - 3:05 PM | Evolving Treatment Paradigms in Melanoma: Targeted and Immune-Based Approaches Michael A. Davies, MD, PhD Chair of the Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center |
| 3:05 PM - 3:10 PM | Skin Cancers Questions and Answers |
| 3:10 PM - 3:25 PM | Coffee Break in Exhibitor Hall |
| 3:25 PM - 3:55 PM | Advancing HER2-Targeted Therapy: Translating Innovation into Practice TBD |
| 3:55 PM - 4:25 PM | Overcoming Endocrine Resistance: Emerging Targets in HR+ Breast Cancer TBD |
| 4:25 PM - 4:55 PM | Precision in Practice: When Molecular Testing in Breast Cancer Changes What You Do Senthil Damodaran, MD, PhD Associate Professor in the Department of Translational Molecular Pathology in the Division of Cancer Medicine The University of Texas MD Anderson Cancer Center |
| 4:55 PM - 5:10 PM | Breast Cancers Questions and Answers |
| 5:10 PM - 5:40 PM | Gynecologic Cancers in the Precision Era: New Strategies, Real Impact Kathleen N. Moore, MD, MS Associate Director of Clinical Research, Stephenson Cancer Center The University of Oklahoma College of Medicine |
| 5:40 PM - 5:45 PM | Gynecologic Cancers Questions and Answers |